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Abstract
Background: In sub-Saharan Africa, knowledge of malaria transmission across rapidly proliferating urban centres
and recommendations for its prevention or management remain poorly defined. This paper presents the results
of an investigation into infection prevalence and treatment of recent febrile events among a slum population in
Nairobi, Kenya.
Methods: In July 2008, a community-based malaria parasite prevalence survey was conducted in Korogocho
slum, which forms part of the Nairobi Urban Health and Demographic Surveillance system. Interviewers visited
1,069 participants at home and collected data on reported fevers experienced over the preceding 14 days and
details on the treatment of these episodes. Each participant was tested for malaria parasite presence with Rapid
Diagnostic Test (RDT) and microscopy. Descriptive analyses were performed to assess the period prevalence of
reported fever episodes and treatment behaviour.
Results: Of the 1,069 participants visited, 983 (92%) consented to be tested. Three were positive for Plasmodium
falciparum using RDT; however, all were confirmed negative on microscopy. Microscopic examination of all 953
readable slides showed zero prevalence. Overall, from the 1,004 participants who have data on fever, 170 fever
episodes were reported giving a relatively high period prevalence (16.9%, 95% CI:13.9%–20.5%) and higher among
children below five years (20.1%, 95%CI:13.8%–27.8%). Of the fever episodes with treatment information 54.3%
(95%CI:46.3%–62.2%) were treated as malaria using mainly sulphadoxine-pyrimethamine or amodiaquine,
including those managed at a formal health facility. Only four episodes were managed using the nationally
recommended first-line treatment, artemether-lumefantrine.
Conclusion: The study could not demonstrate any evidence of malaria in Korogocho, a slum in the centre of
Nairobi. Fever was a common complaint and often treated as malaria with anti-malarial drugs. Strategies, including
testing for malaria parasites to reduce the inappropriate exposure of poor communities to expensive anti-malarial
drugs provided by clinical services and drug vendors, should be a priority for district planners.
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Background
Most studies of urban malaria transmission in sub-Saha-
ran Africa (SSA) suggest significant reductions in the risk
of infection compared to neighbouring rural areas [1-7].
These reduced risks of transmission are, in part, related to
reductions in suitable habitats for dominant vectors [3,8].
However, localized transmission has been associated with
urban agriculture [9,10] and standing permanent water
[11]. Knowledge of transmission across the rapidly prolif-
erating urban centres in Africa and recommendations for
prevention or disease management remain poorly defined
[5,12-15]. The paper presents the results of investigations
of malaria infection prevalence, use of preventative meas-
ures and the treatment of recent febrile events among a
population living in an informal settlement in Nairobi,
Kenya.
Methods
Study area
Nairobi is a classic example of a rapidly growing human
settlement. In 1900, Nairobi was a settlement restricted to
a small area between the Ngong, Mathari and Nairobi riv-
ers and expanded quickly with the building of a railway to
become the colonial government headquarters in 1905.
In 1910, the population of Nairobi was estimated to be
only 1,700 people [16]. By 1944, Nairobi had reached a
total population of 100,000 and was assigned a "city" sta-
tus in 1950, and by 1964 had reached a total population
of approximately 0.3 million with a population density of
544 people per square kilometre. Between 1961 and 1999
Nairobi's population grew to an estimated 2.14 million
with a population density of 3,060 people per square kil-
ometre [17]. This rate of growth has led to the establish-
ment of informal settlements providing mixtures of semi-
permanent and make-shift accommodation for in-
migrants seeking employment. Between 1971 and 1995,
the number of informal, "slum" settlements within the
boundaries of greater Nairobi rose from 50 to 134, and
the estimated population of these settlements increased
from 167,000 to 1.9 million inhabitants [18].
Nairobi was historically an area of seasonal malaria trans-
mission with as many as 939 clinical cases documented
each year between 1930 and 1939 [19] and epidemics
were documented in 1926, 1935 and 1940 [20,21,19]. In
1912,  Anopheles gambiae and  Anopheles funestus were
reported as present within the city [22] and confirmed as
vectors of malaria in 1926 [23]. Plasmodium falciparum
infection prevalence among children was reported to be
2.5% in 1929 [19] and 25% in 1946 [24]. Following
World War II, there was a decline in reported malaria cases
within the city to an average of 261 per year, coinciding
with rapid population growth [19,3]. A forty year period
elapsed before a systematic survey of malaria infection
was reported again. In 1982, P. falciparum infection prev-
alence was reported to be between 1.8% and 13.5% at
nine schools across Nairobi [25]. Despite the low preva-
lence of infection, in 2001 malaria was the second highest
disease diagnosed among attendees to outpatient clinics
after respiratory tract infections and represented 10.6% of
all diagnoses in Nairobi [26].
The present study was undertaken at Korogocho, a slum
settlement that forms part of an extended Nairobi Urban
Health and Demographic Surveillance System (NUHDSS)
established in 2002 to prospectively monitor vital, social
and health events [27]. Korogocho is characterized by
poor environmental sanitation, low coverage of toilets,
absence of sewers or drainage systems and limited access
to safe drinking water [28,29]. The slum is occupied by
26,600 people living in 8,800 households on an area of
less than 0.6 square kilometres. Korogocho slum is
located between Gitathuru River in the north and the Nai-
robi River in the south (Figure 1). Most houses are made
of mud and timber with roofing of waste tin cans. Because
of the poor drainage system there are stagnant water pools
between the dwellings. The slum is served by 15 formal,
public health facilities including two government run
health centres, seven facilities run by faith-based organiza-
tions or non-governmental organizations and six clinics
supported directly by community funds. These services are
augmented with an estimated 96 private, for-profit health
care providers and 128 retail outlets selling over-the-coun-
ter medicines including anti-malarials.
Study population
The NUHDSS population census is routinely updated and
the present study used the de jure residents at 1st January
2008 as the sampling frame. All residents of the Korogo-
cho NUHDSS on this date were eligible to be sampled and
included in the study if they consented. Using simple ran-
dom sampling 1,069 individuals were selected. Field-
workers visited households of the sampled individuals to
seek their consent to participate in a cross-sectional
malaria parasite prevalence survey.
Data collection
Four teams of trained interviewers, each comprising of a
laboratory technician and a nurse collected the data on
individuals who consented to participate in the study.
Since the survey involved an oral interview and finger
prick blood sampling, individuals could consent to be
interviewed but refuse to provide a blood sample. Individ-
uals who consented to participate were interviewed about
the usual and previous night use of mosquito nets and
whether these were treated with insecticide. Participants
were also asked about fever symptoms experienced over
the last 14 days preceding the visit and details on the treat-
ment of these episodes. This information was asked for
every reported fever episode and included how the feverMalaria Journal 2009, 8:160 http://www.malariajournal.com/content/8/1/160
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was detected, the duration of the fever, the type (including
formulation) of medicine taken and the origin of the
medicine.
After the interview, participants who consented to be
tested were finger pricked and a rapid diagnostic test
(RDT: Acu-Check®, Mannheim, Germany) performed. The
RDTs were read 10 minutes after preparation and a confir-
mation reading was done 20 minutes later. The interview-
ers also prepared thick and thin slides and labelled them
with the participant's identification number. Participants
were provided with the results of the RDT and those pos-
itive were given treatment with Coartem®  (artemeter-
lumefantrine), the recommended first-line treatment for
malaria in Kenya [30].
Slides prepared in the field were transported the same day
to the site office for staining with 3% Giemsa. Two hun-
dred high power magnification fields were examined per
slide by two independent laboratory technicians with
experience in reading malaria slides. Where readings were
discrepant a third reading was used as arbitration. In addi-
tion all RDT positive results were re-read again by three
independent technicians for parasitological confirmation.
Data processing and statistical analysis
Data were entered in a database designed in SQL Server
2000 [31] and analyzed using Stata version 9.1 [32].
Descriptive analysis included point and period prevalence
(the reference period was two weeks preceding the inter-
view) computed with 95% confidence intervals stratified
by age and sex. The proportion of fever cases treated by
Study area: location of Nairobi in Kenya (top left panel); location of Korogocho in Nairobi (bottom left panel); distribution of  households in Korogocho (top right panel) and Google Earth image of Korogocho slum (accessed January 2009) Figure 1
Study area: location of Nairobi in Kenya (top left panel); location of Korogocho in Nairobi (bottom left panel); 
distribution of households in Korogocho (top right panel) and Google Earth image of Korogocho slum 
(accessed January 2009).
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origin of the medicine, type of anti-malarial medicine,
and lag between onset of the fever and beginning of treat-
ment, for different age groups was computed.
Ethical approval
The proposal was approved by the KEMRI/National Ethi-
cal Review Committee (SSC number 1227).
Results
Study participants
Of the 1,069 participants 111 (10.4%) individuals
reported to have travelled out of Nairobi in the eight
weeks preceding the interview. Of the 1,069 residents
interviewed, 87 (8.9%) refused to provide a finger prick
blood sample. 52% of the 1,069 interviewees were female
and 63% were aged 15 years or older.
Malaria infection and bed net use
Three (0.3%) participants were reported to have a positive
P. falciparum RDT result at the time of interview. After six
separate examinations of 200 high power magnification
fields of the thick smears of the three RDT positives, all
were defined as microscopically negative. Among all the
slides taken during the survey 12 (1.2%) were damaged
before being read and an additional 18 (1.9%) were
poorly stained and unable to be read. Of the 953 remain-
ing readable slides all were reported as negative for the
presence of sexual or asexual forms of P. falciparum, Plas-
modium malariae and Plasmodium ovale.
Of the 1,069 participants 110 (10.3%) reported owning a
bed net and 103 (9.6%) sharing with another member of
the household. The majority (55.8%) of the bed nets
owned by study participants were treated with insecticide;
of which 38% were pre-treated and 17.8% treated by the
owner. Among participants who reported to have access to
a bed net (owning and sharing), 88.7% slept under the net
the night preceding the survey.
Period prevalence of self-reported fever episodes
Information on self-reported fever was missing for 31
(0.3%) individuals. Of the remainder, 34 (0.3%) said that
they did not know whether they had had a fever or not
and, therefore, analysis was restricted to 1,004 interview-
ees. Overall 170 (16.9%, 95% CI: 13.9%–20.5%) fever
episodes in the last 14 days were reported among 136 peo-
ple. Thirty people reported more than one febrile event
and four people reported more than two febrile events.
The highest reported fever rate was reported for children
less than five years by their parents or guardians (20.1%,
95% CI: 13.8%–27.8%). Self-reported fever prevalence
was lower among age groups 5–9 years (6.9%, 95%CI:
3.2%–12.6%) and 10–14 year (8.9%, 95% CI: 4.4%–
15.8%) however, period prevalence increased to 19.8%
(95% CI: 16.7%–23.1%) among participants aged 15
years or older (Table 1). There were no differences
between males and females in any age group.
Diagnosis and treatment of fever
Participants reported that fevers were diagnosed mostly by
a feeling of the body being hot (71.8%) but some of the
cases were diagnosed in health facilities (27.1%). 1.2% of
the fever episodes were diagnosed at home using a ther-
mometer.
Among the 170 febrile episodes reported, 8 (4.7%) did
not have information on treatment. Of the 162 febrile epi-
sodes with information of treatment, no action was taken
to manage the event for 74 (45.7%). Among the 88 fevers
for which an action was taken 85 reported using a modern
medicine and three used herbs obtained from traditional
healer (Additional file 1), 34.1% of these medicine events
occurred on the same or next day from the onset of symp-
toms and 52.3% after three or more days (Additional file
1). 44.3% of treated fevers were managed at formal public
sector health facilities and 17% of fevers paid for medi-
cines at private clinics/pharmacists. 28.4% of fevers were
treated using medicines purchased from one of the esti-
Table 1: Self-reported fever episodes in the past 14 days preceding the surveys
Characteristics Population* Episodes Period prevalence (%) [95% CI]
1,004 170 16.9 [14.7–19.4]
Gender
Female 524 89 17 [13.9–20.5]
Male 480 81 16.9 [13.6–20.5]
Age group (Years)
0–4 139 28 20.1 [13.8–27.8]
5–9 131 9 6.9 [3.2–12.6]
10–14 112 10 8.9 [4.4–15.8]
15 + 622 123 19.8 [16.7–23.1]
* The total population used is 1,004 instead of 1,069 because information on fever was missing for 31 participants and 34 said they don't knowMalaria Journal 2009, 8:160 http://www.malariajournal.com/content/8/1/160
Page 5 of 7
(page number not for citation purposes)
mated 128 retail outlets selling over-the-counter drugs
within the slum area. Patients older than 15 years were
more likely to seek medicines from the retail sector
(47.7%) compared to only 16.7% of fevers in children
aged less than five years (Additional file 1).
Of the medicines prescribed or self-purchased 32 (36.4%)
of interviewees could not adequately describe the medi-
cines they used nor did they have any packaging remain-
ing for interviewers to ascribe the formulation to either an
anti-malarial preparation or other oral medications.
Among the 56 febrile events for which a medicine type
could be established 31 (55.4%) were identified as
branded forms of sulphadoxine-pyrimethamine (SP) and
16 (28.6%) were classified as a formulation of amodi-
aquine (AQ). Interestingly one fever was treated with
chloroquine, an anti-malarial drug discontinued as rec-
ommended therapy eight years earlier, and one fever was
treated with oral quinine, a drug reserved for second-line
therapy. Only four fevers, all among adults, were man-
aged using the nationally recommended first-line treat-
ment for malaria, Coartem® or artemether-lumefantrine
(AL). Of the identified anti-malarial drugs used to manage
53 fevers 16 were sourced from the informal retail sector
as over-the-counter medicines, 12 were prescribed and
purchased from a private clinic or pharmacy and 23 were
prescribed at the formal, public sector. Within the public
sector the tendency was to prescribe SP or AQ and in only
four of consultations within this sector and for which the
respondent could remember or show evidence of drug-
type did the febrile patient take AL.
Discussion
There remains some controversy over the likelihood and
extent of authochronus malaria transmission within Nai-
robi city [33,34]. Nairobi has grown into a massive urban
sprawl in the last few decades with intense population
growth in informal settlements. This study of an urban
slum community was unable to show any evidence of
peripheral infection with malaria parasite among 953 res-
idents. The study took place after the rains in July 2008
and at a time when ambient temperatures remained suit-
able for sporogony to complete in either An. gambiae s.s,
An. funestus or Anopheles arabiensis. The results do not pre-
clude the possibilities of local malaria transmission in this
area, but strongly suggest that should transmission occur
it would be at exceptionally low levels, representing very
rare events. Furthermore, the findings should not be inter-
preted as excluding the possibilities of malaria transmis-
sion in other parts of Nairobi with different settled
population densities and surrounding environments, a
wider series of investigations would be required to charac-
terize malaria risks across Nairobi's complex and vast lim-
its. There is also a need for an entomological study to
characterize the mosquito population and assess the spo-
rozoite rate to able to rule out any local transmission.
Importantly, however, the observation that there were no
individuals who were harbouring infection does provide
a context to understand the appropriateness of fever case-
management practices in this community. Fever was a rel-
atively common complaint in two-week recall period
among residents of Korogocho, 12.7% of the sampled
population complained of having had a fever and 170
febrile events were recorded among 136 people. Consist-
ent with other fever surveys across Africa [5,6] many
febrile events are not managed using medicines or any
specific interventions and one assumes these fevers are
self-limiting and transient. However actions were taken to
manage 88 (51.8%) fevers among Korogocho residents,
85 (96.6%) were managed with some form of pharmaceu-
tical product of which we were able to document through
interview and observation and found that 53 (62.3%)
were treated with an anti-malarial preparation. Assuming
an equivalent drug-exposure history across every two-
week period in a year this would represent a minimum
estimate of 1.3 anti-malarial drug exposures per person
every year in an area where we were unable to detect any
local malaria transmission.
Only four of the anti-malarial treatments that could be
identified were AL, the nationally recommended first-line
treatment, and the majority were either mono-therapies
drugs not recommended in the national treatment guide-
lines (AQ) or therapies abandoned because of wide-
spread resistance (SP and chloroquine). Regardless of
appropriate treatment regimens the combined findings of
zero parasite prevalence and high anti-malarial use sug-
gests that community and prescriber/dispenser education
on the need to establish the diagnosis using parasitologi-
cal detection is critical in this urban setting. These pleas
have been made to support fever case management in
other urban settings [5,6,35]) and areas of low transmis-
sion in East Africa [36,37]. The transition from cheap,
readily available mono-therapies to more expensive,
restricted access artemisinin-based combination therapy
(ACT) in Kenya in 2006 [38] should serve as a further
financial incentive to minimize over-diagnosis and inap-
propriate drug management through applied diagnostics
[39,40].
Should diagnosis based on systematic testing for malaria
parasites be promoted as a strategy in Nairobi to reduce
inappropriate malaria treatment it is important to extend
its implementation and support to sectors beyond the for-
mal public sector. Over 52.8% of all fevers treated with a
documented anti-malarial in the present study used med-
icines obtained from the private and retail sectors. These
prolific and hard to regulate service providers must beMalaria Journal 2009, 8:160 http://www.malariajournal.com/content/8/1/160
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engaged in strategies to reduce anti-malarial drug use in
areas where malaria transmission is negligible or non-
existent. Failure to do so will perpetuate the dogma that
all fevers in all communities are due to malaria, which
may be good for private sector market sales but poor for
public health practice.
Conclusion
The study could not demonstrate any evidence of malaria
in Korogocho, an urban slum in the centre of Nairobi;
however, fever was a common complaint and often
treated as malaria with anti-malarial drugs. Strategies to
reduce the population exposure to anti-malarial drugs
should be a priority for all clinical services and drug ven-
dors among the poor communities that make up Nai-
robi's informal settlements.
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